Trxade Group to Present at March Investor Conferences

Rhea-AI Summary

Trxade Group (NASDAQ:MEDS) will present at several virtual investor conferences in March 2021. CEO Suren Ajjarapu will host pre-recorded presentations and participate in one-on-one meetings.

The events include:

• H.C. Wainwright Global Life Sciences Conference: March 9-10, 2021.
• ROTH Growth Stock Conference: March 15-17, 2021.
• Maxim Group Emerging Growth Conference: March 17-18, 2021.

Trxade Group specializes in digitalizing the retail pharmacy experience, operating a drug procurement marketplace with over 11,800 members.

TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced that management will present at the following virtual investor conferences during the month of March 2021.

Suren Ajjarapu, Chief Executive Officer of Trxade Group, is scheduled to host pre-recorded virtual presentations during each of the conferences as follows and will participate in one-on-one meetings throughout the day at each event.

H.C. Wainwright Global Life Sciences Conference - Virtual
Date: March 9-10, 2021
Webcast: https://journey.ct.events/view/8cfa08e4-915d-4989-a019-0fce11513fa3

ROTH Growth Stock Conference - Virtual
Date: March 15-17, 2021
Webcast: https://wsw.com/webcast/roth35/meds/1821357

Maxim Group Emerging Growth Conference - Virtual
Date: March 17-18, 2021
Website: https://www.m-vest.com/events/2021-emerging-growth-virtual-conference

Audio webcasts and an archive of the conference presentations will be available using the webcast links above. For more information on a conference, or to schedule a one-on-one, please contact your H.C. Wainwright, ROTH or Maxim Group representative.

About Trxade Group, Inc.
Trxade Group (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 11,800+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on Trxade Group, please visit the Company's IR website at investors.trxadegroup.com.

Investor Relations:
Lucas Zimmerman
Senior Vice President
MZ Group - MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us

SOURCE: Trxade Group, Inc.

View source version on accesswire.com:
https://www.accesswire.com/633625/Trxade-Group-to-Present-at-March-Investor-Conferences

FAQ

What conferences will Trxade Group (MEDS) participate in March 2021?

Trxade Group will participate in the H.C. Wainwright Global Life Sciences Conference on March 9-10, ROTH Growth Stock Conference on March 15-17, and Maxim Group Emerging Growth Conference on March 17-18.

Who is the CEO of Trxade Group presenting at the conferences?

Suren Ajjarapu is the CEO of Trxade Group and will be presenting at the upcoming investor conferences.

Where can I find the webcasts for Trxade Group's presentations?

Webcasts for Trxade Group's presentations can be found through the links provided in their press release for each respective conference.

What is the focus of Trxade Group's business model?

Trxade Group focuses on digitalizing the retail pharmacy experience by optimizing drug procurement and enhancing patient engagement.

How many members does Trxade Group serve with its drug procurement marketplace?

Trxade Group serves over 11,800 members nationwide through its drug procurement marketplace.